XML 45 R38.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS (Tables)
12 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Cost of revenues
$
1.2

 
$
1.3

 
$
0.9

Research and development
2.2

 
1.8

 
1.5

Selling, general and administrative (1)
8.3

 
6.9

 
6.0

Total share-based compensation expense
$
11.7

 
$
10.0

 
$
8.4

(1) Includes allocated share-based compensation of $0.8 million for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:
 
Employee Stock Option Plan
 
Employee Stock Purchase Plans
 
Fiscal Year
 
Fiscal Year
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Expected term (in years)
4.6

 
4.8

 
4.2

 
0.5

 
0.5

 
0.5

Risk-free interest rate
2.5
%
 
2.6
%
 
1.6
%
 
2.5
%
 
2.0
%
 
1.0
%
Expected volatility
33.9
%
 
31.8
%
 
23.6
%
 
43.9
%
 
34.1
%
 
28.0
%
Expected dividend
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
Weighted average fair value at grant date
$10.19
 
$11.57
 
$8.08
 
$7.81
 
$8.92
 
$7.81

Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts and the remaining term)
Options
 
Price range
 
Weighted Average
Exercise Price
 
Weighted Average Remaining Term (in years)
 
Aggregate Intrinsic Value (1)
Outstanding at September 28, 2018
2,011
 
$22.63 — $37.60
 
$
30.35

 
 
 
 
Granted
297
 
$31.42 — $31.42
 
31.42

 
 
 
 
Canceled, expired or forfeited
(4)
 
$31.08 — $31.08
 
31.08

 
 
 
 
Exercised
(35)
 
$22.84 — $27.77
 
23.38

 
 
 
 
Outstanding at September 27, 2019
2,269
 
$22.63 — $37.60
 
$
30.60

 
4.1
 
$
1,220.3

Exercisable at September 27, 2019
1,477
 
$22.63 — $37.60
 
$
29.67

 
3.4
 
$
1,220.3

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $28.28 as of September 27, 2019, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts)
Number of Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 28, 2018
641
 
$
33.60

Granted
288
 
31.29

Vested
(201)
 
31.56

Canceled or expired
(50)
 
34.13

Balance at September 27, 2019
678
 
$
33.18